Drug Conviction Data in KASPER: What is a Pharmacist to Do?

This educational initiative is a component of a grant from the Bureau of Justice Assistance to evaluate data-driven response to prescription drug misuse in Kentucky.

The main objective of this educational initiative is to develop and provide needed continuing education for prescribers and dispensers on the content and interpretation of conviction data within KASPER.

Target Audience

Kentucky prescribers and dispensers that use and interpret the conviction data in KASPER

Learning Objectives

Upon completion of this educational activity, participants will be able to:

  • Discuss implications of SB 32 that made drug conviction data available in KASPER effective July 1, 2018
  • Review results of Kentucky prescriber and dispenser survey on intent to use drug conviction data in KASPER
  • Assess current data regarding the use of drug conviction data in KASPER by prescribers and dispensers
Course summary
Available credit: 
  • 1.50 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 1.50 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

  • 1.50 Participation
    UK Healthcare CECentral certifies this activity for 1.50 hour(s) of participation.
Course opens: 
05/01/2023
Course expires: 
05/01/2026
Rating: 
0
Patricia R.  Freeman
Patricia R. Freeman, RPh, PhD, FAPhA
Associate Professor and Director
Center for the Advancement of Pharmacy Practice
University of Kentucky College of Pharmacy
Lexington, Kentucky

 

Dana L.  Quesinberry
Dana L. Quesinberry, JD, DrPH
Assistant Professor, Associate Director of the KIPRC
Kentucky Injury Prevention and Research Center - University of Kentucky

Disclosure
The speaker, planners, or reviewers do not have any relevant financial relationships to disclose. 

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Acknowledgment
This project was supported by Grant No. 2017-PM-BX-K026 (Data-Driven Responses to Prescription Drug Misuse in Kentucky) awarded by the Bureau of Justice Assistance (BJA) to the Kentucky Injury Prevention and Research Center as bona fide agent for the Kentucky Department for Public Health.

The BJA is a component of the Department of Justice’s Office of Justice Program, which includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office of Victims Crime, and the SMART Office.

Viewpoints or opinions in these programs are those of the authors and do not necessarily represent the official position or policies of the US Department of Justice.

 


In support of improving patient care, University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Available Credit

  • 1.50 ACPE

    In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

    This knowledge-based activity will award 1.50 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

  • 1.50 Participation
    UK Healthcare CECentral certifies this activity for 1.50 hour(s) of participation.
Please login or register to take this course.